Medha Agarwal

Medha Agarwal is a General Partner at defy.vc since October 2023 and serves on the board of Synthpop - Healthcare AI from April 2024. Agarwal has been an investor at Whatnot since November 2021 and at LiveKit since January 2022, as well as at BIOAGE Labs since January 2019, where the company achieved an IPO ($BIOA). Additionally, Agarwal has board roles at Tend since March 2019 and Anvyl from December 2018 to September 2024. Previous investment responsibilities include Proper, a Y Combinator W22 company that underwent acquisition, from January 2022 to April 2024, and Tendies and OnPlan from April 2021 to November 2023. Agarwal holds a Master of Business Administration from Harvard Business School and a Bachelor of Arts in Social Studies from Harvard University.